Affordable Access

Publisher Website

Platelet binding of IgG from patients with heparininduced thrombocytopenia

Authors
Journal
Journal of Laboratory and Clinical Medicine
0022-2143
Publisher
Elsevier
Publication Date
Volume
127
Issue
5
Identifiers
DOI: 10.1016/s0022-2143(96)90060-8
Disciplines
  • Biology

Abstract

Abstract Although heparin induces immune-mediated thrombocytopenia, it has been difficult to demonstrate heparin specificity of the putative immunoglobin. Recently, however, a body of data has indicated that platelet factor 4 (PF4) is required for heparin-induced thrombocytopenia (HIT) antibody to bind to heparin. Using viable platelets in a physiologic buffer, we have now documented specific and reversible platelet binding of iodine 125-labeled IgG from 5 patients with HIT and binding of 125I-labeled F(ab′) 2 from 2 of them. The binding requires the presence of both heparin and PF4 in a molar ratio of ∼ 1:1. We have also shown that platelet activation increases HIT antibody binding. Our data suggest that the F(ab′) 2 domain of HIT antibody binds to heparin-PF4 complexes that accumulate on the platelet surface when equimolar concentrations of heparin and PF4 are present.

There are no comments yet on this publication. Be the first to share your thoughts.